# Filing Detail

Form 10-QT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001641172-25-027041
Filing Date
2025-09-10
Accepted
2025-09-10 16:06:11
Documents
68
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-QT | form10-qt.htm iXBRL | 10-QT | 921684
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 19569
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 19520
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 10764
| Complete submission text file | 0001641172-25-027041.txt |  | 5185000

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | ptix-20250630.xsd | EX-101.SCH | 42266
6 | XBRL CALCULATION FILE | ptix-20250630_cal.xml | EX-101.CAL | 55931
7 | XBRL DEFINITION FILE | ptix-20250630_def.xml | EX-101.DEF | 204948
8 | XBRL LABEL FILE | ptix-20250630_lab.xml | EX-101.LAB | 343857
9 | XBRL PRESENTATION FILE | ptix-20250630_pre.xml | EX-101.PRE | 279801
70 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-qt_htm.xml | XML | 688663

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-QT | Act: 34 | File No.: 001-12555 | Film No.: 251305941
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)